Network-Wide Clinical Trials Program
SCOA has engaged in a unique joint venture with Translational Research Management (TRM), a market leader in building networks of community-based medical oncology professionals dedicated to offering cutting edge research studies to their patients. The SCOA/TRM partnership is creating a solution to the pressing need in cancer research to build bridges between community oncologists, drug developers and patients.
Drug companies that utilize SCOA’s clinical trial network ensure the proper placement and streamlined management of their clinical trials, thus generating higher quality data and significantly faster results.
SCOA oncologists can then make available these novel therapeutics as an integrated part of their continuum of care, improving the number and quality of clinical trials they can offer patients, and offering them in a community setting. This includes Phase 2 and 3 level clinical trials.